secwatch / observer
DBD DIEBOLD NIXDORF, Inc
CIK 0000028823 50 ready 8-Ks latest July 29, 2026, 7:06 AM ET RSS · JSON
Activity: QUIET 0 filings / 30d vs 1 baseline
Ready 8-Ks 50
Latest filing July 29, 2026, 7:06 AM ET
Top materiality 1.00
Event mix other_material ×15 · earnings ×13 · debt ×9
Sentiment 15 pos · 12 neg · 23 neu
Latest earnings reported 2026-Q1
Executive change recent →

Recent 8-K filings for DBD

Executive changes

Appointed

Dr. Colin J. Parris

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2024-08-02
Filed
August 7, 2024, 7:59 PM ET
appointed Dr. Colin J. Parris to the Board, effective immediately, to fill the vacancy created by the increase.
Appointed

Maura A. Markus

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2024-08-06
Filed
August 7, 2024, 7:59 PM ET
appointed Maura A. Markus to the Board, effective immediately, to fill the vacancy created by the increase.
Appointed

Thomas S. Timko

Executive Vice President and Chief Financial Officer
DBD · DIEBOLD NIXDORF, Inc
Effective
2024-05-17
Filed
April 25, 2024, 7:59 PM ET
On April 19, 2024, Diebold Nixdorf, Incorporated (the “Company”) agreed to an offer letter (the “Offer Letter”) with Thomas S. Timko, pursuant to which Mr. Timko has agreed to serve as Executive Vice President and Chief Financial Officer of the Company.
Appointed

Mark Gross

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2023-09-22
Filed
September 28, 2023, 7:59 PM ET
On September 22, 2023, the Board of Directors (the “Board”) of Diebold Nixdorf, Incorporated (the “Company”) increased the size of the Board from seven to eight members and appointed Patrick J. Byrne, age 63, Matthew J. Espe, age 65, Mark Gross, age 60, and David H. Naemura, age 64, to the Board, effective immediately, to fill the three prior vacancies on the Board as well as the additional vacancy created by the increase.
Appointed

Patrick J. Byrne

Chair of the Board
DBD · DIEBOLD NIXDORF, Inc
Effective
2023-09-22
Filed
September 28, 2023, 7:59 PM ET
In addition, Mr. Byrne was appointed as Chair of the Board.
Appointed

Patrick J. Byrne

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2023-09-22
Filed
September 28, 2023, 7:59 PM ET
On September 22, 2023, the Board of Directors (the “Board”) of Diebold Nixdorf, Incorporated (the “Company”) increased the size of the Board from seven to eight members and appointed Patrick J. Byrne, age 63, Matthew J. Espe, age 65, Mark Gross, age 60, and David H. Naemura, age 64, to the Board, effective immediately, to fill the three prior vacancies on the Board as well as the additional vacancy created by the increase.
Appointed

Matthew J. Espe

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2023-09-22
Filed
September 28, 2023, 7:59 PM ET
On September 22, 2023, the Board of Directors (the “Board”) of Diebold Nixdorf, Incorporated (the “Company”) increased the size of the Board from seven to eight members and appointed Patrick J. Byrne, age 63, Matthew J. Espe, age 65, Mark Gross, age 60, and David H. Naemura, age 64, to the Board, effective immediately, to fill the three prior vacancies on the Board as well as the additional vacancy created by the increase.
Appointed

David H. Naemura

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2023-09-22
Filed
September 28, 2023, 7:59 PM ET
On September 22, 2023, the Board of Directors (the “Board”) of Diebold Nixdorf, Incorporated (the “Company”) increased the size of the Board from seven to eight members and appointed Patrick J. Byrne, age 63, Matthew J. Espe, age 65, Mark Gross, age 60, and David H. Naemura, age 64, to the Board, effective immediately, to fill the three prior vacancies on the Board as well as the additional vacancy created by the increase.
Departed

David Caldwell

Executive Vice President, Strategy & Corporate Development
DBD · DIEBOLD NIXDORF, Inc
Filed
August 18, 2023, 7:59 PM ET
The Company has also notified David Caldwell, the Company’s Executive Vice President, Strategy & Corporate Development, that his position will be eliminated.
Appointed

Elizabeth C. (Lisa) Radigan

Executive Vice President, Chief Legal Officer and Secretary
DBD · DIEBOLD NIXDORF, Inc
Filed
August 18, 2023, 7:59 PM ET
Elizabeth C. (Lisa) Radigan, has succeeded Mr. Leiken as the Company’s Executive Vice President, Chief Legal Officer and Secretary.
Departed

Jonathan B. Leiken

Executive Vice President, Chief Legal Officer and Secretary
DBD · DIEBOLD NIXDORF, Inc
Successor
Elizabeth C. (Lisa) Radigan
Filed
August 18, 2023, 7:59 PM ET
As previously disclosed, Jonathan B. Leiken, Executive Vice President, Chief Legal Officer and Secretary of the Company, is resigning to accept another senior executive position outside of the Company.
Departed

Olaf Heyden

Executive Vice President, Chief Operating Officer
DBD · DIEBOLD NIXDORF, Inc
Effective
2024-02-24
Filed
August 18, 2023, 7:59 PM ET
the Company notified Olaf Heyden, the Company’s Executive Vice President, Chief Operating Officer, that his service agreement will not be renewed and will otherwise expire on February 24, 2024 in accordance with its term.

Earnings & guidance

2026-Q1 EPS reported $0.14 filing →

Materiality & sentiment trend

Max materiality 1.00 · Median 0.72 · Most common event other_material

15 positive 12 negative 23 neutral

source · DBD on sec.gov